Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 1/20 | 0.36 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PTPRC | P08575 | 2/20 | 0.34 |
| ▸ | CTSL | P07711 | 1/20 | 0.34 |
| ▸ | CTSS | P25774 | 1/20 | 0.34 |
| ▸ | PTPN13 | Q12923 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | TDP2 | O95551 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.33 |
| ▸ | CES1 | P23141 | 1/20 | 0.33 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16623745 | 0.92 | JAK2 (0.40) | JAK2CYP19A1ALDH1A1HTTHSD17B10 | |
| SCHEMBL16623753 | 0.88 | JAK2 (0.43) | JAK2CYP19A1ALDH1A1HTTHSD17B10 | |
| SCHEMBL16623855 | 0.84 | CYP19A1 (0.36) | JAK2CYP19A1ALDH1A1MEN1KMT2A | |
| SCHEMBL16623703 | 0.80 | GPR3 (0.42) | JAK2CYP19A1ALDH1A1MEN1KMT2A | |
| SCHEMBL16623762 | 0.80 | GPR3 (0.42) | JAK2CYP19A1ALDH1A1MEN1KMT2A | |
| SCHEMBL16623766 | 0.80 | GPR3 (0.42) | JAK2CYP19A1ALDH1A1MEN1KMT2A | |
| SCHEMBL17521551 | 0.79 | GPR3 (0.41) | JAK2CYP19A1ALDH1A1MEN1KMT2A | |
| SCHEMBL16623851 | 0.77 | CYP19A1 (0.39) | JAK2CYP19A1ALDH1A1GAACYP1A2 | |
| SCHEMBL16623854 | 0.77 | JAK2 (0.40) | JAK2CYP19A1GAACYP1A2CYP3A4 | |
| SCHEMBL16623768 | 0.75 | GPR3 (0.43) | JAK2CYP19A1ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180047913-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | JNC CORPORATION (JP) | 2018-02-15 | — | — | US | disclosed |
| US-9741950-B2 | Polycyclic aromatic compound | KYOTO UNIVERSITY (JP) | 2017-08-22 | — | — | US | disclosed |
| US-20160049600-A1 | POLYCYCLIC AROMATIC COMPOUND | SK MATERIALS JNC CO., LTD. (KR) | 2016-02-18 | — | — | US | disclosed |
| US-9166176-B2 | Polycyclic aromatic compound | KYOTO UNIVERSITY (JP) | 2015-10-20 | — | — | US | disclosed |
| US-20150097162-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | JNC CORPORATION (JP) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180047913-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, DISPLAY DEVICE, AND LIGHTING DEVICE | L1CAM, VDAC1, VDAC2 | JAK2 1814/4885CYP19A1 2633/4885ALDH1A1 2463/4885 |
| US-20160049600-A1 | POLYCYCLIC AROMATIC COMPOUND | BICRA, PAH, SMARCC2 | JAK2 39/4885CYP19A1 450/4885ALDH1A1 1610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.